Francesco De Rose

Francesco De Rose has worked in the pharmaceutical industry since 2021, when they became the Head of Pharmaceutical Development at NUCLIDIUM AG. Prior to that, they were a Postdoctoral Researcher and PhD Student at Klinikum rechts der Isar der TU M\u00fcnchen from 2015 to 2021. In 2014, they completed an internship at A.O.U. Citta della Salute e della Scienza di Torino.

Francesco De Rose obtained a Bachelor's degree in Chimica from Università della Calabria in 2008-2012. Francesco then obtained a Master's degree in Chimica Clinica Forense e dello Sport from Università degli Studi di Torino in 2012-2015. In 2016, they obtained a Theoretical and Practical Qualification to the Ordinance on Animal Protection in Experiments from TransMIT GmbH. Finally, they obtained a Doctor of Philosophy - PhD in Experimental Medicine from Technical University of Munich in 2015-2020.